SKF 525-A induces cocaine N-demethylase, ethoxyresorufin O-deethylase, and pentoxyresorufin O-dealkylase activities by induction of cytochrome P-450 2B in female B6C3F1 mice

Journal of Toxicology and Environmental Health - Part A

Volumn 67, Issue 23-24, 2004, Pages 1955-1970

  Tae, Cheon Jeong ^a   Hyeun, Wook Chang ^a   Eung, Seok Lee ^a   Tae, Won Jeon ^a   Hye, Gwang Jeong ^b   Holsapple, Michael P ^c  

^a Yeungnam University   (South Korea)

^b Chosun University   (South Korea)

^c International Life Sciences Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; CYTOCHROME P450 1A; CYTOCHROME P450 2B; ENZYME ANTIBODY; ETHOXYRESORUFIN DEETHYLASE; FORMALDEHYDE; MONOCLONAL ANTIBODY; N DEMETHYLASE; PENTOXYRESORUFIN DEALKYLASE; PROADIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME METABOLISM; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; IN VITRO STUDY; ISOENZYME ANALYSIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SHEEP ERYTHROCYTE; WESTERN BLOTTING;

ANIMALS; COCAINE; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 ENZYME SYSTEM; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; ENZYME INHIBITORS; FEMALE; MICE; OXIDOREDUCTASES, N-DEMETHYLATING; PROADIFEN;

ANIMALIA; OVIS ARIES;

EID: 8444224262     PISSN: 15287394     EISSN: None     Source Type: Journal    
DOI: 10.1080/15287390490514606     Document Type: Conference Paper

References (35)

1. Bandiera, S., Ryan, D. E., Levin, W., and Thomas, P. E. 1986. Age- and sex-related expression of cytochromes P450f and P450g in rat liver. Arch. Biochem. Biophys. 248:658-676.
2. Blank, J. A., Tucker, A. N., Sweatlock, J., Gasiewicz, T. A., and Luster, M. I. 1987. á-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p- dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression. Mol. Pharmacol. 32:168-172.
3. Boelsterli, U. A., Lanzotti, A., Göldlin, C., and Oertle, M. 1992. Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes. Drug Metab. Dispos. 20:96-101.
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Buening, M. K., and Franklin, M. R. 1976. SKF 525-A inhibition, induction, and 452-nm complex formation. Drug Metab. Dispos. 4:244-255.
6. Burke, M. D., and Meyer, R. T. 1975. Inherent specificities of purified cytochrome P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation. Drug Metab. Dispos. 3:245-253.
7. Dannan, G. A., Guengerich, F. P., Kaminsky, L. S., and Aust, S. D. 1983. Regulation of cytochrome P-450: Immunochemical quantitation of eight isozymes in liver microsomes of rats treated with polybrominated biphenyl congeners. J. Biol. Chem. 258:1282-1288.
8. Evans, M. A. 1983. Role of protein binding in cocaine-induced hepatotoxicity. J. Pharmacol. Exp. Ther. 224:73-79.
9. Gonzalez, F. J. 1988. The molecular biology of cytochrome P-450s. Pharmacol. Rev. 40:243-288.
10. Guengerich, F. P., Dannan, G. A., Wright, S. T., Martin, M. V., and Kaminsky, L. S. 1982. Purification and characterization of rat liver microsomal cytochromes P-450: Electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight enzymes isolated from rats treated with phenobarbital or β-napthoflavone. Biochemistry 21:6019-6030.
11. Halpert, J. R., Guengerich, F. P., Bend, J. R., and Correia, M. A. 1994. Selective inhibitors of cytochromes P-450. Toxicol. Appl. Pharmacol. 125:163-175.
12. Iversen, P. L., and Franklin, M. R. 1985. Microsomal cytochrome P-450 "handprints": Five fractions from anion-exchange high-pressure liquid chromatography provide a rapid preliminary screen for selectivity in the induction and destruction of rat hepatic cytochrome P-450 subpopulations. Toxicol. Appl. Pharmacol. 78:1-9.
13. Jeong, T. C., Jordan, S. D., Matulka, R. A., Stanulis, E. D., Kamiski, E. J., and Holsapple, M. P. 1995. Role of metabolism by esterase and cytochrome P-450 in cocaine-induced suppression of the antibody response. J. Pharmacol. Exp. Ther. 272:407-416.
14. Jeong, T. C., Jordan, S. D., Matulka, R. A., Stanulis, E. D., Park, S. S., and Holsapple, M. P. 1996. Immunosuppression induced by acute exposure to cocaine is dependent on metabolism by cytochrome P-450. J. Pharmacol. Exp. Ther. 276:1257-1265.
15. Jeong, T. C., Lee, E. S., Chae, W., Koh, W. S., Kang, B.-H., and Han, S. S. 2002. Immunotoxic effects of 2-bromopropane in male Sprague-Dawley rats: A 28-day exposure study. J. Toxicol. Environ. Health A 65:383-394.
16. Kim, B. S., Kim, D. H., Holsapple, M. P., and Yang, K. H. 1989. Immunosuppressive effects of 2-acetylaminofluorene and 2-aminofluorene on murine splenocytes culture. Drug chem. Toxicol. 12:297-311.
17. LeDuc, B. W., Sinclair, P. R., Walton, H. S., Sinclair, J. F., Greenblatt, D. J., and Shuster, L. 1994. Cocaine toxicity in cultured chicken hepatocytes: Role of cytochrome P-450. Toxicol. Appl. Pharmacol. 125:322-332.
18. Lee, H. S., Lee, H. Y., Gu, H. K., Han, S. S., Yun, C.-H., Kim, J. H., Kim, J. A., Lee, E. S., Nam, D. H., and Jeong, T. C. 2000. Effects of flupyrazofos on liver microsomal cytochrome P450 in the male Fischer 344 rats. Xenobiotica 30:1123-1130.
19. Lubet, R. A., Meyer, R. T., Cameron, J. W., Nims, R. W., Burke, M. D., Wolff, T., and Guengerich, F. P. 1985. Dealkylation of pentoxyresorufin: A rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch. Biochem. Biophys. 238:43-48.
20. Luster, M. I., Munson, A. E., Thomas, P., Holsapple, M. P., Fenters, J., White, K. L., Jr., Lauer, L. D., Germolec, D. R., Rosenthal, G. J., and Dean, J. H. 1988. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fund am. Appl. Toxicol. 10:2-19.
21. Matsunaga, T., Nagata, K., Tanaka, E., Oguri, K., and Yoshimura, H. 1986. Effect of co-administration of interferon inducer, polyriboinosinic acid-polyribocytidylic acid, with SKF 525-A on hepatic drug metabolizing enzymes of rats. J. Pharmacobio-Dyn. 9:638-644.
22. Murray, M. 1988. Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF 525-A-induced rats. Arch. Biochem. Biophys. 262:381-388.
23. Nash, T. 1953. The colorimetrical estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J. 55:416-421.
24. Nelson, D. R., Kamataki, T., Waxman, D. J., Guengerich, F. P., Estabrook, R. W., Feyereisen, R., Gonzalez, F. J., Coon, M. J., Gunsalus, I. C., Gotoh, O., Okuda, K., and Nebert, D. W. 1993. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 12:1-51.
25. Nerurka, P. V., Park, S. S., Thomas, P. E., Nims, R. W., and Lubet, R. A. 1993. Methoxyresorufin and benzyloxyresorufin: substrate preferentially metabolized by cytochromes P450 1A2 and 2B, respectively, in the rat and mouse. Biochem. Pharmacol. 46:933-943.
26. Park, S. S., Fujino, T., West, D., West, F. D., Guengerich, F. P., and Gelboin, H. V. 1982. Monoclonal antibodies that inhibit enzyme activity of 3-methylcholanthrene-induced cytochrome P-450. Cancer Res. 42:1798-1803.
27. Park, S. S., Fujino, T., Miller, H., Guengerich, F. P., and Gelboin, H. V. 1984. Monoclonal antibodies to phenobarbital-induced rat liver cytochrome P-450. Biochem. Pharmacol. 3:2071-2081.
28. Pike, S. F., Shephard, E. A., Rabin, B. R., and Phillips, I. R. 1985. Induction of cytochrome P-450 by phenobarbital is mediated at the level of transcription. Biochem. Pharmacol. 34:2489-2494.
29. Roth, L., Harbison, R. D., James, R. C., Tobin, T., and Roberts, S. M. 1992. Cocaine hepatotoxicity: Influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis. Hepatology 15:934-940.
30. Schenkman, J. B., Wilson, B. J., and Cinti, D. L. 1972. Diethylaminoethyl 2,2-diphenylvalerate HCI (SKF 525-A) - In vivo and in vitro effects of metabolism by rat liver microsomes - Formation of an oxygenated complex. Biochem. Pharmacol. 21:2373-2383.
31. Thomas, P. E., Reik, L. M., Ryan, D. E., and Levin, W. 1981. Regulation of three forms of cytochrome P-450 and epoxide hydroxylase in rat liver microsomes. J. Biol. Chem. 256:1046-1052.
32. Thomas, P. E., Bandiera, S., Maines, S. L., Ryan, D. E., and Levin, W. 1987. Regulation of cytochrome P-450j, a high-affinity. N-nitrosodimethylamine demethylase, in rat hepatic microsomes. Biochemistry 26:2280-2289.
33. Thompson, M. L., Shuster, L., and Shaw, K. 1979. Cocaine-induced hepatic necrosis in mice-role of cocaine metabolism. Biochem. Pharmacol. 28:2389-2395.
34. Watkins, P. B. 1990. Role of cytochromes P450 in drug metabolism and hepatotoxicity. Sem. Liver Dis. 10:235-250.
35. Yamada, H., Kaneko, H., Takeuchi, K., Oguri, K., and Yoshimura, H. 1992. Tissue-specific expression, induction, and inhibition through metabolic intermediate-complex formation of guinea pig cytochrome P450 belonging to the CYP2B subfamily. Arch. Biochem. Biophys. 299:248-254.